Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nitschmann

Showing results (111-120 of 222) with videos related to

Pageof 23
Sort By:
Der Internist|April 17, 2019
[Treatment options for patients with suboptimally controlled type 1 diabetes]S Martin, S Nitschmann
Innere Medizin (Heidelberg, Germany)|February 22, 2023
[Lecanemab in the treatment of Alzheimer's disease]O Peters, S Nitschmann
Der Internist|August 17, 2021
[Obesity treatment with semaglutide]M Blüher, S Nitschmann
Der Internist|June 7, 2020
[Association between angiotensin blockade and incidence of influenza A virus infection]C Hamm, S Nitschmann
Der Internist|November 11, 2020
[Significant weight reduction by diet normalizes metabolic function in obesity and Type 2 diabetes to the same extent as gastric bypass]W A Scherbaum, S Nitschmann
Der Internist|September 3, 2016
[Treatment options for asymptomatic carotid artery stenosis : Asymptomatic Carotid Trial (ACT I) and Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)]H-C Diener, S Nitschmann
Der Internist|September 5, 2018
[Cardiovascular risk in gout patients : Cardiovascular Safety of Febuxostat or Allopurinol in Participants with Gout and Cardiovascular Comorbidities (CARES)]D Müller-Wieland, S Nitschmann
Der Internist|July 14, 2011
[Ω-3 fatty acids after myocardial infarction : Alpha Omega Trial]C von Schacky, S Nitschmann
Der Internist|July 27, 2010
[New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)]U R Fölsch, S Nitschmann
Der Internist|March 21, 2009
[Rosuvastatin in patients with chronic heart failure]U C Hoppe, S Nitschmann
Pageof 23

Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Der Internist|April 17, 2019
[Treatment options for patients with suboptimally controlled type 1 diabetes]S Martin, S Nitschmann
Innere Medizin (Heidelberg, Germany)|February 22, 2023
[Lecanemab in the treatment of Alzheimer's disease]O Peters, S Nitschmann
Der Internist|August 17, 2021
[Obesity treatment with semaglutide]M Blüher, S Nitschmann
Der Internist|June 7, 2020
[Association between angiotensin blockade and incidence of influenza A virus infection]C Hamm, S Nitschmann
Der Internist|November 11, 2020
[Significant weight reduction by diet normalizes metabolic function in obesity and Type 2 diabetes to the same extent as gastric bypass]W A Scherbaum, S Nitschmann
Der Internist|September 3, 2016
[Treatment options for asymptomatic carotid artery stenosis : Asymptomatic Carotid Trial (ACT I) and Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)]H-C Diener, S Nitschmann
Der Internist|September 5, 2018
[Cardiovascular risk in gout patients : Cardiovascular Safety of Febuxostat or Allopurinol in Participants with Gout and Cardiovascular Comorbidities (CARES)]D Müller-Wieland, S Nitschmann
Der Internist|July 14, 2011
[Ω-3 fatty acids after myocardial infarction : Alpha Omega Trial]C von Schacky, S Nitschmann
Der Internist|July 27, 2010
[New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)]U R Fölsch, S Nitschmann
Der Internist|March 21, 2009
[Rosuvastatin in patients with chronic heart failure]U C Hoppe, S Nitschmann
Pageof 23